Up-to-date improvements in inorganic ring systems as anticancer agents.
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis*; D001388:Aziridines / Q000138:chemical synthesis* / Q000627:therapeutic use; D001389:Azirines / Q000138:chemical synthesis*; D004353:Drug Evaluation, Preclinical; D007939:Leukemia L1210 / Q000188:drug therapy; D007941:Leukemia P388 / Q000188:drug therapy; D013058:Mass Spectrometry; D008545:Melanoma / Q000188:drug therapy; D008722:Methods; D051379:Mice; D008968:Molecular Conformation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009943:Organophosphorus Compounds / Q000138:chemical synthesis* / Q000627:therapeutic use; D051381:Rats; D013059:Spectrum Analysis, Raman; D013329:Structure-Activity Relationship; D014961:X-Ray Diffraction
D000970:Antineoplastic Agents; D001388:Aziridines; D001389:Azirines; D009943:Organophosphorus Compounds